Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Apr 7;17(4):e81835.
doi: 10.7759/cureus.81835. eCollection 2025 Apr.

Carbamazepine-Induced Oral Lichenoid Reaction: A Report of a Rare Case

Affiliations
Case Reports

Carbamazepine-Induced Oral Lichenoid Reaction: A Report of a Rare Case

Gokhan Cinar et al. Cureus. .

Abstract

Lichenoid drug reactions (LDRs) are rare adverse effects that resemble lichen planus both clinically and histopathologically. Although cutaneous involvement is more common, oral manifestations are relatively uncommon. Carbamazepine, a widely used antiepileptic drug, has been associated with various cutaneous adverse reactions, but oral lichenoid reactions (OLRs) due to carbamazepine are rarely reported. In this case report, we present a 62-year-old male patient who developed painful white reticular plaques on the buccal mucosa and lateral borders of the tongue after using carbamazepine for approximately 14 months. The lesions completely regressed within three weeks following the discontinuation of the drug. No dental restorations or other possible local irritants were detected. Although histopathological confirmation could not be obtained due to the patient's refusal of a biopsy, the clinical appearance and full remission after drug cessation strongly supported the diagnosis. This case highlights the importance of considering drug-induced OLRs in the differential diagnosis of oral mucosal lesions, especially in patients using medications known to cause lichenoid eruptions. Early recognition and discontinuation of the offending drug are crucial for resolution and patient comfort.

Keywords: adverse drug reaction; buccal mucosa; carbamazepine; drug-induced lesions; oral lichenoid reaction.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. White reticular and hyperkeratotic plaques with erythematous changes before drug discontinuation
Clinical presentation of oral lichenoid reaction induced by carbamazepine. (a) Reticular white plaques and erythematous areas on the buccal mucosa. (b, c) Hyperkeratotic white plaques and erythematous changes observed on the lateral borders of the tongue.
Figure 2
Figure 2. Mucosal healing following discontinuation of carbamazepine
Follow-up clinical images demonstrating regression of oral lichenoid lesions. (a) The dorsal surface of the tongue shows complete resolution of previous hyperkeratotic plaques. (b) The ventral surface of the tongue has regained normal mucosal texture. (c) The buccal mucosa appears normal with no visible reticular or erythematous changes.

Similar articles

References

    1. Lichenoid drug reactions [Article in German] Merk HF, Vanstreels L, Megahed M. Hautarzt. 2018;69:116–120. - PubMed
    1. Cutaneous lichenoid drug eruptions: a narrative review evaluating demographics, clinical features and culprit medications. Maul JT, Guillet C, Oschmann A, et al. J Eur Acad Dermatol Venereol. 2023;37:965–975. - PubMed
    1. Lichenoid drug eruptions. Halevy S, Shai A. J Am Acad Dermatol. 1993;1:249–255. - PubMed
    1. Skin reactions to carbamazepine. Roberts DL, Marks R. Arch Dermatol. 1981;117:273–275. - PubMed
    1. Lichenoid reaction to carbamazepine in the oral mucosa: case report. Artico G, Bruno IS, Seo J, Hirota SK, Acay R, Migliari DA. An Bras Dermatol. 2011;86:0–5. - PubMed

Publication types

LinkOut - more resources